Abstract
Vaccine development is inherently different from therapeutic drug development. Each step in vaccine development is influenced by the perceived value of the vaccine to be developed. That perception of value begins with the public who, ultimately, determine how important they consider the prevention of a given disease. Unfortunately, the public commonly undervalues the impact, and therefore value, of disease prevention in general. As a result, the full disease prevention potential of vaccines has yet to be realized. Smallpox has been eradicated by vaccine. Polio may soon be eradicated by vaccine. Measles, tetanus, diphtheria, and pertussis have been markedly reduced. But, considering the potential for the control or elimination of diseases with vaccine, we have only scratched the surface.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ada, G., 1993, HIV-towards Phase III trials for candidate vaccines, Nature 364:489–490.
Blackwelder, W. C., Storsaeter, J., Olin, P., and Hallander, H. O., 1991, Acellular pertussis vaccines. Efficacy and evaluation of clinical case definitions, Am. J. Dis. Child. 145:1285–1289.
Carter, R., 1966, Breakthrough. The Saga of Jonas Salk, Trident Press, New York.
Francis, D. P., Hadler, S. C., Thompson, S. E., Maynard, J. E., Ostrow, D. G., Altman, N., Braff, E. H., O’Malley, P., Hawkins, D., Judson, F. N., Penley, K., Nylund, T., Christie, G., Meyers, F., Moore, J. N., Jr., Gardner, A., Doto, I. L., Miller, J. H., Reynolds, G. H., Murphy, B. L., Schable, C. A., Clark, B. T., Curran, J. W., and Redeker, A. G., 1982, The prevention of hepatitis B with vaccine. Report of the CDC multi-center efficacy trial among homosexual men, Ann. Intern. Med. 97:362–366.
Maupas, P., Goudeau, A., Coursaset, P., and Druker, J., 1976, Immunisation against hepatitis B in man, Lancet 1:289–292.
Purcell, R. H., Gerin, J. L., 1975, Hepatitis B subunit virus vaccine: A preliminary report of safety and efficacy tests in chimpanzees, Am. J. Med. Sci. 270:395–399.
Redeker, A. G., Mosley, J. W., Gocke, D. J., McKee, A. P., and Pollack, W., 1975, Hepatitis B immune globulin as a prophylactic measure for spouses exposed to acute type B hepatitis, N. Engl. J. Med. 293:1055.
Smith, J., 1990, Patenting the Sun. Polio and the Salk Vaccine, Morrow, New York.
Szmuness, W., Stevens, C. E., Harley, E. J., Zang, E. A., Oleszko, W. R., William, D. C., Sadovsky, R., Morrison, J. M., and Kellner, A., 1980, Hepatitis B vaccine. Demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States, N. Engl. J. Med. 303:833–841.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer Science+Business Media New York
About this chapter
Cite this chapter
Francis, D.P. (1995). Laboratory Empiricism, Clinical Design, and Social Value. In: Powell, M.F., Newman, M.J. (eds) Vaccine Design. Pharmaceutical Biotechnology, vol 6. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1823-5_6
Download citation
DOI: https://doi.org/10.1007/978-1-4615-1823-5_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5737-7
Online ISBN: 978-1-4615-1823-5
eBook Packages: Springer Book Archive